Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanno Glimm

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
Cancer Letters|December 19, 2015
Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cellsTaronish D Dubash, Christopher M Hoffmann, Felix Oppel, et al.
BMC Bioinformatics|May 30, 2019
TelomereHunter - in silico estimation of telomere content and composition from cancer genomesLars Feuerbach, Lina Sieverling, Katharina I Deeg, et al.
Oncoimmunology|April 14, 2017
PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcomaJan Budczies, Gunhild Mechtersheimer, Carsten Denkert, et al.
NPJ Genomic Medicine|April 3, 2025
Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APCAlexandra A Baumann, Lisanne I Knol, Marie Arlt, et al.
Blood|January 6, 2016
Increased DNA methylation of Dnmt3b targets impairs leukemogenesisIsabell Schulze, Christian Rohde, Marina Scheller-Wendorff, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 12, 2020
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseAnne Katrin Berger, Sadaf Shabbir Mughal, Michael Allgäuer, et al.
JCO Precision Oncology|May 31, 2024
Exceptional Response of <i>BRAF</i><sup>V600E</sup>-Mutated Acinar Cell CUP to BRAF/MEK InhibitionIrina A Kerle, Anne-Marie Scheuble, Benjamin Kobitzsch, et al.
JCO Precision Oncology|July 2, 2025
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in ChordomaDaniel S Lefler, Andrew Elliott, Wei Jiang, et al.
Cell Reports|February 19, 2026
ACSL4-associated lipid metabolism is a distinct therapeutic vulnerability in KMT2A-rearranged acute myeloid leukemiaSilvia Schäfer, Elahe Rahimian, Lola Schmitz-Hübsch, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2025
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncologyDamian T Rieke, Michael Bitzer, Annalen Bleckmann, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Cancer Letters|December 19, 2015
Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cellsTaronish D Dubash, Christopher M Hoffmann, Felix Oppel, et al.
BMC Bioinformatics|May 30, 2019
TelomereHunter - in silico estimation of telomere content and composition from cancer genomesLars Feuerbach, Lina Sieverling, Katharina I Deeg, et al.
Oncoimmunology|April 14, 2017
PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcomaJan Budczies, Gunhild Mechtersheimer, Carsten Denkert, et al.
NPJ Genomic Medicine|April 3, 2025
Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APCAlexandra A Baumann, Lisanne I Knol, Marie Arlt, et al.
Blood|January 6, 2016
Increased DNA methylation of Dnmt3b targets impairs leukemogenesisIsabell Schulze, Christian Rohde, Marina Scheller-Wendorff, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 12, 2020
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseAnne Katrin Berger, Sadaf Shabbir Mughal, Michael Allgäuer, et al.
JCO Precision Oncology|May 31, 2024
Exceptional Response of <i>BRAF</i><sup>V600E</sup>-Mutated Acinar Cell CUP to BRAF/MEK InhibitionIrina A Kerle, Anne-Marie Scheuble, Benjamin Kobitzsch, et al.
JCO Precision Oncology|July 2, 2025
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in ChordomaDaniel S Lefler, Andrew Elliott, Wei Jiang, et al.
Cell Reports|February 19, 2026
ACSL4-associated lipid metabolism is a distinct therapeutic vulnerability in KMT2A-rearranged acute myeloid leukemiaSilvia Schäfer, Elahe Rahimian, Lola Schmitz-Hübsch, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2025
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncologyDamian T Rieke, Michael Bitzer, Annalen Bleckmann, et al.
Pageof 15